These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 23121727)

  • 1. Dopamine D2 receptor SPECT in corticobasal syndrome and autopsy-confirmed corticobasal degeneration.
    Pirker S; Perju-Dumbrava L; Kovacs GG; Traub-Weidinger T; Asenbaum S; Pirker W
    Parkinsonism Relat Disord; 2013 Feb; 19(2):222-6. PubMed ID: 23121727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progressive Dopamine Transporter Binding Loss in Autopsy-Confirmed Corticobasal Degeneration.
    Pirker S; Perju-Dumbrava L; Kovacs GG; Traub-Weidinger T; Pirker W
    J Parkinsons Dis; 2015; 5(4):907-12. PubMed ID: 26485425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FP-CIT- and IBZM-SPECT in Corticobasal Syndrome: Results from a Clinical Follow-Up Study.
    Hammesfahr S; Antke C; Mamlins E; Beu M; Wojtecki L; Ferrea S; Dinkelbach L; Moldovan AS; Schnitzler A; Müller HW; Südmeyer M
    Neurodegener Dis; 2016; 16(5-6):342-7. PubMed ID: 26978429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of [123I]IBZM pinhole SPECT for the detection of striatal dopamine D2 receptor availability in rats.
    Scherfler C; Scholz SW; Donnemiller E; Decristoforo C; Oberladstätter M; Stefanova N; Diederen E; Virgolini I; Poewe W; Wenning GK
    Neuroimage; 2005 Feb; 24(3):822-31. PubMed ID: 15652317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alzheimer's disease and corticobasal degeneration presenting as corticobasal syndrome.
    Hu WT; Rippon GW; Boeve BF; Knopman DS; Petersen RC; Parisi JE; Josephs KA
    Mov Disord; 2009 Jul; 24(9):1375-9. PubMed ID: 19425061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopamine transporters, D2 receptors, and glucose metabolism in corticobasal degeneration.
    Klaffke S; Kuhn AA; Plotkin M; Amthauer H; Harnack D; Felix R; Kupsch A
    Mov Disord; 2006 Oct; 21(10):1724-7. PubMed ID: 16773621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pathology of corticobasal syndrome].
    Wakabayashi K; Miki Y
    Brain Nerve; 2013 Jan; 65(1):9-18. PubMed ID: 23300099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Corticobasal degeneration.
    Saranza GM; Whitwell JL; Kovacs GG; Lang AE
    Int Rev Neurobiol; 2019; 149():87-136. PubMed ID: 31779825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Dopamine (D2) receptor SPECT with 123I-iodobenzamide (IBZM) in diagnosis of Parkinson syndrome].
    Reiche W; Grundmann M; Huber G
    Radiologe; 1995 Nov; 35(11):838-43. PubMed ID: 8657887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fulminant corticobasal degeneration: a distinct variant with predominant neuronal tau aggregates.
    Ling H; Gelpi E; Davey K; Jaunmuktane Z; Mok KY; Jabbari E; Simone R; R'Bibo L; Brandner S; Ellis MJ; Attems J; Mann D; Halliday GM; Al-Sarraj S; Hedreen J; Ironside JW; Kovacs GG; Kovari E; Love S; Vonsattel JPG; Allinson KSJ; Hansen D; Bradshaw T; Setó-Salvia N; Wray S; de Silva R; Morris HR; Warner TT; Hardy J; Holton JL; Revesz T
    Acta Neuropathol; 2020 Apr; 139(4):717-734. PubMed ID: 31950334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [123I]IBZM SPECT for imaging of striatal D2 dopamine receptors in 56 schizophrenic patients taking various neuroleptics.
    Klemm E; Grünwald F; Kasper S; Menzel C; Broich K; Danos P; Reichmann K; Krappel C; Rieker O; Briele B; Hotze AL; Möller HJ; Biersack HJ
    Am J Psychiatry; 1996 Feb; 153(2):183-90. PubMed ID: 8561197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopamine Transporter SPECT Imaging in Corticobasal Syndrome.
    Cilia R; Rossi C; Frosini D; Volterrani D; Siri C; Pagni C; Benti R; Pezzoli G; Bonuccelli U; Antonini A; Ceravolo R
    PLoS One; 2011 May; 6(5):e18301. PubMed ID: 21559307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined 123I-FP-CIT and 123I-IBZM SPECT for the diagnosis of parkinsonian syndromes: study on 72 patients.
    Plotkin M; Amthauer H; Klaffke S; Kühn A; Lüdemann L; Arnold G; Wernecke KD; Kupsch A; Felix R; Venz S
    J Neural Transm (Vienna); 2005 May; 112(5):677-92. PubMed ID: 15375677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Iodine-123-iodobenzamide SPECT assessment of dopamine D2 receptor occupancy in riperidone-treated schizophrenic patients.
    Dresel S; Tatsch K; Dähne I; Mager T; Scherer J; Hahn K
    J Nucl Med; 1998 Jul; 39(7):1138-42. PubMed ID: 9669383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Associated alterations of striatal dopamine D2/D3 receptor and transporter binding in drug-naive patients with schizophrenia: a dual-isotope SPECT study.
    Yang YK; Yu L; Yeh TL; Chiu NT; Chen PS; Lee IH;
    Am J Psychiatry; 2004 Aug; 161(8):1496-8. PubMed ID: 15285982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SPECT study of the nigrostriatal dopaminergic system in Huntington's disease.
    Hwang WJ; Yao WJ
    J Neuroimaging; 2013 Apr; 23(2):192-6. PubMed ID: 22211920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparison of D2 receptor scintigraphy (123I-IBZM) with cerebral perfusion (99m-Tc-HMPAO) in extrapyramidal disorders].
    Saur HB; Bartenstein P; Schober O; Oberwittler C; Lerch H; Masur H
    Nuklearmedizin; 1994 Oct; 33(5):184-8. PubMed ID: 7997375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of dopamine-D2 receptor binding sites in Parkinsonian plus syndromes.
    Hierholzer J; Cordes M; Venz S; Schelosky L; Harisch C; Richter W; Keske U; Hosten N; Mäurer J; Poewe W; Felix R
    J Nucl Med; 1998 Jun; 39(6):954-60. PubMed ID: 9627325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. D2-dopamine receptor occupancy measured by IBZM-SPECT in relation to extrapyramidal side effects.
    Broich K; Grünwald F; Kasper S; Klemm E; Biersack HJ; Möller HJ
    Pharmacopsychiatry; 1998 Sep; 31(5):159-62. PubMed ID: 9832346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebral Glucose Metabolism and Dopaminergic Function in Patients with Corticobasal Syndrome.
    Mille E; Levin J; Brendel M; Zach C; Barthel H; Sabri O; Bötzel K; Bartenstein P; Danek A; Rominger A
    J Neuroimaging; 2017 Mar; 27(2):255-261. PubMed ID: 27572945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.